Skin is increasingly understood as a reflection of internal balance rather than a problem limited to the surface. Conditions such as psoriasis and eczema highlight this connection. Both are chronic, ...

Topline data were announced from two phase 3 trials evaluating amlitelimab for the treatment of moderate to severe atopic dermatitis.

Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...

As an increasing number of cases are identified in clinics, medical professionals believe that Malaysia must enhance public awareness and improve food labelling to protect better individuals who are ...

Corvus Pharmaceuticals soared by 211.8 percent week-on-week to hit a new all-time high, as investors cheered the strong ...

Jia Patrick told Newsweek that living with TSW has been "a truly harrowing experience" that will take a long time to recover ...

Corvus Pharmaceuticals extended its winning streak to a 6th straight session on Thursday to hit a new all-time high, as ...

Sanofi (EPA: SASY) has announced encouraging late-stage clinical trial results for its investigational drug amlitelimab, ...

Sanofi said its amlitelimab drug confirmed its potential to treat eczema in patients 12 years and older in two late-phase ...

The two-time U.S. Olympic gold medalist gymnast opens up about her skin condition, her fashion dos and don’ts for eczema, and ...

Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of children and adults. It often causes itching, redness, dryness, flaking, and sometimes ...

Winter has a way of turning everything chapped. Your hands, face, lips, elbows, knees — the list goes on. It’s the seasonal tax nearly everyone pays if they’re not armed with serious moisture. Push it ...